Peptonic Medical AB terminates the distribution agreement with Yuanjia Bio for the Chinese market
Stockholm, August 13[th] 2021. Peptonic Medical (publ) (‘Peptonic’ or ‘the Company’) informs that the distribution agreement with Yuanjia Biotechnology Co., Ltd. concerning VagiVital® AktivGel for the Chinese market has been terminated.The reason for the termination is a payment default where Yuanjia Biotechnology Co., Ltd. has failed to pay Peptonic Medical a total of EUR 406’. Half of the value for an order in November 2020 and subsequent shipment to China and the other half for an order in February 2021 where the goods is still in Finland. As a consequence q2 results will be negatively